Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barton

Showing results (11-20 of 749) with videos related to

Pageof 75
Sort By:
The American Journal of Physiology|August 1, 1984
Active transport of lead-210 by everted segments of rat duodenumJ C Barton
Cancer|August 1, 1989
Tumor lysis syndrome in nonhematopoietic neoplasmsJ C Barton
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Deferasirox NovartisJames C Barton
Drugs|March 28, 2007
Optimal management strategies for chronic iron overloadJames C Barton
Idrugs : the Investigational Drugs Journal|March 29, 2007
Drug evaluation: deferitrin (GT-56-252; NaHBED) for iron overload disordersJames C Barton
Scientifica|November 27, 2013
Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomeRichard C Barton
The Journal of the Kentucky Medical Association|July 1, 1994
Health system reformD C Barton
The Hospital|May 30, 2018
Honours and the Nursing ProfessionEleanor C Barton
Ecology and Evolution|August 25, 2020
Impacts of the COVID-19 pandemic on field instruction and remote teaching alternatives: Results from a survey of instructorsDaniel C Barton
Journal of Medical Microbiology|January 8, 2011
Candida rugosa: a new fungal pathogen emerging, but from where?Richard C Barton
Pageof 75

Showing results (11-20 of 749) with videos related to

Sort By:
Pageof 75
The American Journal of Physiology|August 1, 1984
Active transport of lead-210 by everted segments of rat duodenumJ C Barton
Cancer|August 1, 1989
Tumor lysis syndrome in nonhematopoietic neoplasmsJ C Barton
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Deferasirox NovartisJames C Barton
Drugs|March 28, 2007
Optimal management strategies for chronic iron overloadJames C Barton
Idrugs : the Investigational Drugs Journal|March 29, 2007
Drug evaluation: deferitrin (GT-56-252; NaHBED) for iron overload disordersJames C Barton
Scientifica|November 27, 2013
Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomeRichard C Barton
The Journal of the Kentucky Medical Association|July 1, 1994
Health system reformD C Barton
The Hospital|May 30, 2018
Honours and the Nursing ProfessionEleanor C Barton
Ecology and Evolution|August 25, 2020
Impacts of the COVID-19 pandemic on field instruction and remote teaching alternatives: Results from a survey of instructorsDaniel C Barton
Journal of Medical Microbiology|January 8, 2011
Candida rugosa: a new fungal pathogen emerging, but from where?Richard C Barton
Pageof 75